Movano Inc. (MOVE)
NASDAQ: MOVE · Real-Time Price · USD
5.29
+0.34 (6.79%)
Dec 3, 2024, 12:11 PM EST - Market open
Movano Employees
Movano had 30 employees as of December 31, 2023. The number of employees decreased by 4 or -11.76% compared to the previous year.
Employees
30
Change (1Y)
-4
Growth (1Y)
-11.76%
Revenue / Employee
$30,067
Profits / Employee
-$835,633
Market Cap
35.06M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 30 | -4 | -11.76% |
| Dec 31, 2022 | 34 | 7 | 25.93% |
| Dec 31, 2021 | 27 | 12 | 80.00% |
| Dec 31, 2020 | 15 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Nortech Systems | 775 |
| Neuronetics | 203 |
| IRIDEX | 111 |
| Precision Optics Corporation | 85 |
| NextCure | 82 |
| Chemomab Therapeutics | 20 |
| Akari Therapeutics, | 12 |
| Marker Therapeutics | 8 |
MOVE News
- 1 day ago - Movano Health Receives FDA Clearance for EvieMED Ring - PRNewsWire
- 18 days ago - Movano Inc. (MOVE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 18 days ago - Movano Health Reports Q3 2024 Financial Results and Provides Business Update - PRNewsWire
- 26 days ago - Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device - PRNewsWire
- 27 days ago - Movano Health to Report Third Quarter 2024 Financial Results on Thursday November 14, 2024 - PRNewsWire
- 4 weeks ago - Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split - PRNewsWire
- 4 weeks ago - Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED - PRNewsWire
- 4 weeks ago - Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split - PRNewsWire